The neuroprotective mechanism of cinnamaldehyde against amyloid-β in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and adenosine receptors and glycogen synthase kinase-3β

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 385

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-9-3_008

تاریخ نمایه سازی: 7 خرداد 1398

Abstract:

Objective: Cinnamaldehyde may be responsible for some health benefits of cinnamon such as its neuroprotective effects. We aimed to investigate the cinnamaldehyde neuroprotective effects against amyloid beta (Aβ) in neuronal SHSY5Y cells and evaluate the contribution of N-methyl-D-aspartate (NMDA), ryanodine, and adenosine receptors and glycogen synthase kinase (GSK)-3β, to its neuroprotective effects. Materials and Methods: After seeding the cells in 96-well plates, adenosine (20, 40, 80, and 120 µM), NMDA (20, 40, 80, and 120 µM), and dantrolene (as a ryanodine receptor antagonist; 2, 4, 6, 8, and 16 µM) were added to the medium containing Aβ25-35 and/or cinnamaldehyde. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide method was used to assess neurotoxicity and western blot to measure the GSK-3β protein level. Results: Cinnamaldehyde (15, 20, 23, and 25 μM) significantly reversed Aβ-induced toxicity in SHSY5Y neuronal cells. Adenosine (20, 40, 80 and 120 μM) inhibited the neuroprotective effects of cinnamaldehyde (15 μM). NMDA (20, 40, 80, and 120 μM) reduced cinnamaldehyde (15 and 23 μM) neuroprotective effects against Aβ neurotoxicity. Dantrolene (2, 4, 8, and 16 μM) significantly reduced cinnamaldehyde (15 μM) neuroprotective effects. Cinnamaldehyde (15 and 23 μM) suppressed the Aβ-induced increment of GSK-3β protein level.  Conclusion: NMDA and adenosine receptors suppression together with ryanodine receptors stimulation may be relevant to cinnamaldehyde neuroprotective effects against Aβ neurotoxicity. Moreover, the inhibition of GSK-3β may contribute to the cinnamaldehyde neuroprotection.

Authors

Masoumeh Emamghoreishi

Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran|Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.

Majid Farrokhi

Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Atena Amiri

Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Mojtaba Keshavarz

Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Allan Butterfield D. 2002. Amyloid β-peptide (1-42)-induced oxidative stress and ...
  • Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, ...
  • Ataie Z, Mehrani H, Ghasemi A, Farrokhfall K. 2019. Cinnamaldehyde ...
  • Berridge MJ, Bootman MD, Lipp P. 1998. Calcium-a life and ...
  • Bhat RV, Budd Haeberlein SL, Avila J. 2004. Glycogen synthase ...
  • Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, ...
  • Checler F. 1995. Processing of the β-amyloid precursor protein and ...
  • Chen, Wang YW, Huang WS, Lee MM, Wood WG, Leung ...
  • Chen P, Gu Z, Liu W, Yan Z. 2007. Glycogen ...
  • Chui D-H, Tanahashi H, Ozawa K, Ikeda S, Checler F, ...
  • Couturier K, Qin B, Batandier C, Awada M, Hininger-Favier I, ...
  • Dall Igna OP, Fett P, Gomes MW, Souza DO, Cunha ...
  • Dall lgna OP, Porciúncula LO, Souza DO, Cunha RA, Lara ...
  • Danysz W, Parsons CG. 2012. Alzheimer s disease, β-amyloid, glutamate, ...
  • Delacourte A, Buée L. 2000. Tau pathology: a marker of ...
  • Donley J, Hurt W, Stockert A. 2016. Effects of cinnamon ...
  • Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, ...
  • Gomada Y, Jamison BY, Maitin V, Vattem DA. 2012. Cinnamon ...
  • Gomes CV, Kaster MP, Tomé AR, Agostinho PM, Cunha RA. ...
  • Hernandez F, Lucas JJ, Avila J. 2013. GSK3 and tau: ...
  • Ho S-C, Chang K-S, Chang P-W. 2013. Inhibition of neuroinflammation ...
  • Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, ...
  • Keshavarz M, Farrokhi M, Amiri A. 2017. Caffeine neuroprotective mechanism ...
  • Klafke J, Da Silva M, Trevisan G, Rossato M, Da ...
  • Kwon B-M, Lee S-H, Cho Y-K, Bok S-H, So S-H, ...
  • LaFerla FM. 2002. Calcium dyshomeostasis and intracellular signalling in Alzheimer ...
  • Lindeboom J, Weinstein H. 2004. Neuropsychology of cognitive ageing, minimal ...
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein ...
  • Lüscher C, Malenka RC. 2012. NMDA receptor-dependent long-term potentiation and ...
  • Lv C, Yuan X, Zeng H-W, Liu R-H, Zhang W-D. ...
  • McPhersonx PS, Kim Y-K, Valdivia H, Knudson CM, Takekura H, ...
  • Peng J, Liang G, Inan S, Wu Z, Joseph DJ, ...
  • Peterson DW, George RC, Scaramozzino F, LaPointe NE, Anderson RA, ...
  • Phiel CJ, Wilson CA, Lee VM-Y, Klein PS. 2003. GSK-3α ...
  • Sartorius T, Peter A, Schulz N, Drescher A, Bergheim I, ...
  • Shimada Y, Goto H, Kogure T, Kohta K, Shintani T, ...
  • Stavinoha RC, Vattem DA. 2015. Potential neuroprotective effects of cinnamon. ...
  • Supnet C, Bezprozvanny I. 2010. The dysregulation of intracellular calcium ...
  • Szatmari E, Habas A, Yang P, Zheng J-J, Hagg T, ...
  • Takashima A. 2006. GSK-3 is essential in the pathogenesis of ...
  • Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny ...
  • Zhao J, Zhang X, Dong L, Wen Y, Zheng X, ...
  • نمایش کامل مراجع